PPARG and malignant colon neoplasm: Several studies have shown a significant reduction of PPARγ expression in cancers such as colon cancer (210, 211), gastric cancers (212), follicular thyroid cancer (213), cervical carcinoma (214), and esophageal cancer (215) (Figure 3).